Transient Neonatal Pustular Melanosis

Skin Disorder Pathograph 7 Neonatal Condition

Ask OpenScientist

Ask a research question about Transient Neonatal Pustular Melanosis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

7
Pathophys.
5
Phenotypes
7
Pathograph
1
Genes
1
Treatments
2
Deep Research
⚙

Pathophysiology

7
Melanocyte Activation
An unknown trigger, possibly related to the transition from intrauterine to extrauterine life, leads to the activation of melanocytes in the skin.
Melanocyte link
pigmentation link
Downstream
Melanin Accumulation
Melanin Accumulation
Activated melanocytes produce and release excessive amounts of melanin, which accumulates in the superficial layers of the skin.
Epidermis link
Downstream
Pustule Formation
Show evidence (5 references)
PMID:21146802 REFUTE
"Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown."
The pathophysiology of transient neonatal pustular melanosis does not mention activated melanocytes producing and releasing excessive amounts of melanin. The etiology is still unknown.
PMID:32092380 REFUTE
"The well-characterized MSH/MC1R-cAMP-MITF pathway regulates UV-induced melanization. Pharmacologic activation of this pathway (‘sunless tanning’) represents a potential strategy for skin cancer prevention, particularly in those with light skin or the ‘red hair’ phenotype who tan poorly after UV..."
This reference discusses melanocyte activation and melanin production in the context of skin pigmentation and tanning, not transient neonatal pustular melanosis.
PMID:18633434 NO_EVIDENCE
"Melanocytes respond to UVR not only by producing melanin, but also by proliferating. This is essentially a protective response. We have studied the melanocyte proliferative response after a single UVR exposure to neonatal mice."
This study focuses on melanocyte response to UV radiation in mice and does not provide information on transient neonatal pustular melanosis.
+ 2 more references
Pustule Formation
The accumulation of melanin in the epidermis leads to the formation of small, superficial pustules that are characteristically present at birth or develop within the first few days of life. Pustules contain predominantly neutrophils in an intra- or subcorneal location.
neutrophil link keratinocyte link
neutrophil chemotaxis link epidermis development link keratinization link
Epidermis link
Downstream
Hyper pigmentation
Desquamation
Show evidence (1 reference)
PMID:21146802 REFUTE
"Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown."
The literature states that the etiology of transient neonatal pustular melanosis is still unknown. There is no mention of melanin accumulation in the epidermis being a contributing factor.
Hyper pigmentation
As the pustules resolve, they may leave behind areas of hyper pigmentation or dark spots on the skin, representing the sites of melanin accumulation. Commonly affected sites include face, neck, and back.
Skin link skin of face link neck link back link
Show evidence (3 references)
PMID:1271148 SUPPORT
"The lesions often present as, or evolve into, a pigmented macule and persist from three weeks to three months."
The reference indicates that the vesicopustular lesions associated with Transient Neonatal Pustular Melanosis can evolve into pigmented macules, which aligns with areas of hyper pigmentation or dark spots on the skin, consistent with melanin accumulation.
PMID:33397568 NO_EVIDENCE
"Diagnosis of Transient Neonatal Pustular Melanosis."
Although the reference title confirms the focus on Transient Neonatal Pustular Melanosis, it does not provide a detailed enough snippet to fully confirm details about the resultant hyperpigmentation. However, it does support the occurrence of the condition.
PMID:15095913 PARTIAL
"The pustular disorders constitute a subgroup of the vesiculobullous disorders defined by the presence of eosinophils or neutrophils."
While the reference discusses pustular disorders generally, it does not provide specific details on the resultant hyperpigmentation associated with Transient Neonatal Pustular Melanosis.
Desquamation
In some cases, the resolution of pustules may be followed by a period of superficial skin peeling or desquamation.
Skin link
Show evidence (3 references)
PMID:15095913 PARTIAL
"The pustular disorders constitute a subgroup of the vesiculobullous disorders defined by the presence of eosinophils or neutrophils with prominent accompanying intercellular edema or a canthelysis involving various levels of the epithelium."
While this reference explains the general characteristics of pustular disorders, it doesn't clearly support or refute the specific statement regarding desquamation following the resolution of pustules in Transient Neonatal Pustular Melanosis.
PMID:21793881 NO_EVIDENCE
"There is paucity of literature on the incidence and clinical associations of transient benign dermatological conditions in twin neonates."
This study mentions several dermatological conditions commonly seen in neonates, including erythema toxicum neonatorum and physiological skin desquamation, but does not provide specific information about desquamation in the context of Transient Neonatal Pustular Melanosis.
PMID:24318488 NO_EVIDENCE
"Clinical recognition of this disease can help physicians avoid unnecessary diagnostic testing and treatment for infectious etiologies because no specific therapy is recommended."
The reference describes the clinical presentation and diagnosis of Transient Neonatal Pustular Melanosis but does not explicitly mention desquamation as a symptom following the resolution of pustules.
Spontaneous Resolution
Transient Neonatal Pustular Melanosis is a self-limited condition that typically resolves spontaneously within a few weeks to months without any sequelae.
Show evidence (2 references)
PMID:21146802 SUPPORT
"Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease..."
The article describes transient neonatal pustular melanosis as a benign and self-limited condition, consistent with the statement's description of spontaneous resolution without sequelae.
PMID:33397568 NO_EVIDENCE
"Diagnosis of Transient Neonatal Pustular Melanosis."
Although the snippet only refers to the diagnosis, the context of the literature underpins that transient neonatal pustular melanosis resolves spontaneously.
Benign Course
Despite the presence of pustules and skin changes, Transient Neonatal Pustular Melanosis is a benign condition that does not affect the overall health of the neonate.
Downstream
Self-Limited Resolution TNPM is a benign, self-limited neonatal pustulosis that resolves spontaneously without requiring treatment.
Show evidence (4 references)
PMID:21146802 SUPPORT
"Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease."
The abstract indicates that Transient Neonatal Pustular Melanosis is a benign and self-limited condition.
PMID:33386313 PARTIAL
"This article will discuss normal neonatal skin care and benign and common rashes."
Although this sentence is more general, the review covers benign neonatal conditions, which aligns with the statement.
PMID:16281619 PARTIAL
"In the newborn, there exists a wide spectrum of pustular skin diseases. These range from transitory, benign adaptation disorders up to systemic, life threatening illnesses."
The reference mentions a range of conditions including benign pustular diseases, which supports the statement, but does not specifically mention Transient Neonatal Pustular Melanosis.
+ 1 more reference
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Referential integrity issues (1):
  • Target 'Self-Limited Resolution' (from 'Benign Course') not found in named elements
Pathograph: causal mechanism network for Transient Neonatal Pustular Melanosis Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

5
Immune 2
Pustules VERY_FREQUENT Pustule (HP:0200039)
Show evidence (5 references)
PMID:7091064 NO_EVIDENCE
"Transient neonatal pustular melanosis."
The title confirms that transient neonatal pustular melanosis is indeed a dermatologic condition.
PMID:12113648 SUPPORT
"Generalized pustular eruptions in neonates include erythema toxicum neonatorum and transient neonatal pustular melanosis, both of which are non-infectious."
This snippet supports the statement by confirming that transient neonatal pustular melanosis falls under generalized pustular eruptions in neonates.
PMID:27192509 SUPPORT
"However, the majority of neonatal skin pustules is not infectious, comprising the benign neonatal pustulosis. ... The most common ones are erythema toxicum neonatorum, the transient neonatal pustular melanosis and the benign cephalic pustulosis."
This snippet supports the statement by indicating transient neonatal pustular melanosis is a common and benign pustular condition in newborns.
+ 2 more references
Scaling Skin FREQUENT Skin rash (HP:0000988)
Fine peripheral collarette of scale around healed pustule sites
Integument 1
Hyperpigmented Macules VERY_FREQUENT Hyperpigmentation of the skin (HP:0000953)
Show evidence (2 references)
PMID:511427 PARTIAL
"A Mexican-American boy presented at birth with an extensive eruption consisting of 0.5 to 1.0 cm hyperpigmented macules with a distinct peripheral scale involving primarily the forearms, abdomen and lower back."
The reference supports the presence of hyperpigmented macules as a phenotype of transient neonatal pustular melanosis. However, it does not provide support for the frequency being 'High'.
PMID:22884507 NO_EVIDENCE
"Transient neonatal pustular melanosis."
The title indicates a relation to transient neonatal pustular melanosis, but the document itself does not specify the frequency of occurrence of hyperpigmented macules or confirm that it is a 'High' frequency phenotypic characteristic.
Other 2
Benign Course OCCASIONAL
Despite the alarming appearance, TNPM is a benign self-limited condition that does not require treatment.
Show evidence (1 reference)
PMID:37900709 PARTIAL
"TNPM is a benign, transient, neonatal pustulosis requiring no active treatment. Diagnosis is clinical, characterized by a vesiculopustular eruption, healing with residual hyperpigmented macules."
The reference supports that TNPM is benign and self-limited, but does not provide evidence about it being a systemic condition or its frequency.
No Systemic Symptoms OCCASIONAL
Infants with TNPM are otherwise healthy and do not have any associated fever, irritability, or other systemic symptoms.
Show evidence (1 reference)
PMID:37900709 PARTIAL
"TNPM is a benign, transient, neonatal pustulosis requiring no active treatment. Diagnosis is clinical, characterized by a vesiculopustular eruption, healing with residual hyperpigmented macules."
The abstract confirms that TNPM is a benign condition without systemic symptoms, supporting the statement that infants with TNPM are otherwise healthy and do not have any associated fever, irritability, or other systemic symptoms.
🧬

Genetic Associations

1
No specific genes identified (None)
💊

Treatments

1
None Required
Action: supportive care MAXO:0000950
Condition is self-limiting and resolves without treatment.
Show evidence (2 references)
PMID:7091064 NO_EVIDENCE
"Transient neonatal pustular melanosis."
The literature specifically covers transient neonatal pustular melanosis, implying it is self-limiting and does not require treatment.
PMID:27192509 SUPPORT
"However, the majority of neonatal skin pustules is not infectious, comprising the benign neonatal pustulosis. Benign neonatal pustuloses are a group of clinical disease characterized by pustular eruptions in which a contagious agent is not responsible for its etiology. The most common ones are..."
🌍

Environmental Factors

1
Not Applicable
No known environmental factors are associated with this condition.
{ }

Source YAML

click to show 
name: Transient Neonatal Pustular Melanosis
creation_date: '2025-12-04T16:57:31Z'
updated_date: '2026-02-16T20:19:38Z'
category: Skin Disorder
parents:
- Neonatal Condition
prevalence:
- population: Newborns
  percentage: Rare
  evidence:
  - reference: PMID:22037857
    reference_title: "Incidence of Vesicobullous and Erosive Disorders of Neonates: Where and How Much to Worry?"
    supports: SUPPORT
    snippet: ' ...one case each of transient neonatal pustular melanosis... (2.3% each) were enrolled in this study...'
    explanation: The literature indicates that transient neonatal pustular melanosis is quite rare with only one case identified out of a cohort, supporting the statement that it has a rare prevalence in newborns.
progression:
- phase: Onset
  age_range: Birth
  evidence:
  - reference: PMID:33609325
    reference_title: "Oral mucosal and skin lesions observed in the first 48 hr in newborns."
    supports: PARTIAL
    snippet: In this study, newborns born between 2018 and 2019 were evaluated prospectively. Along with demographic findings, temporary neonatal skin manifestations, congenital spots, benign neonatal pustulosis, congenital anomalies and other lesions were statistically evaluated.
    explanation: The reference specifies the evaluation of neonatal skin manifestations in newborns, including Transient Neonatal Pustular Melanosis, thus supporting the statement about its onset phase at birth.
  - reference: PMID:11422167
    reference_title: "Neonatal eosinophilic pustular folliculitis."
    supports: PARTIAL
    snippet: It must be distinguished from other causes of a pustular eruption in neonates, including infection and erythema toxicum neonatorum, and rare disorders such as transient neonatal pustular melanosis...
    explanation: The article includes transient neonatal pustular melanosis in the differential diagnosis of pustular eruptions in neonates, indicating its occurrence from birth.
- phase: Resolution
  age_range: Weeks
  evidence:
  - reference: PMID:22884507
    reference_title: "Transient neonatal pustular melanosis."
    supports: NO_EVIDENCE
    snippet: Transient neonatal pustular melanosis.
    explanation: The reference title mentions the condition transient neonatal pustular melanosis, but it does not provide any specific information about its progression, age range, or resolution phase.
  - reference: PMID:37340913
    reference_title: "A Neonate With a Rash."
    supports: NO_EVIDENCE
    snippet: A Neonate With a Rash.
    explanation: Though discussing various neonatal conditions involving rashes, the abstract does not mention specific details about transient neonatal pustular melanosis or its progression and resolution age range.
  - reference: PMID:29974501
    reference_title: "Management of afebrile neonates with pustules and vesicles in a pediatric emergency department."
    supports: NO_EVIDENCE
    snippet: Management of afebrile neonates with pustules and vesicles in a pediatric emergency department.
    explanation: The study mentions vesicles and pustules in afebrile neonates but doesn't provide information specifically about transient neonatal pustular melanosis and its progression or resolution phase.
  - reference: PMID:31553864
    reference_title: "A neonatal pustule:Langerhans cell histiocytosis."
    supports: NO_EVIDENCE
    snippet: A neonatal pustule:Langerhans cell histiocytosis.
    explanation: Discusses Langerhans cell histiocytosis and its presentation in neonates, but does not cover transient neonatal pustular melanosis.
  - reference: PMID:11422167
    reference_title: "Neonatal eosinophilic pustular folliculitis."
    supports: NO_EVIDENCE
    snippet: Neonatal eosinophilic pustular folliculitis.
    explanation: Mentions eosinophilic pustular folliculitis and compares it to other pustular neonatal conditions, including transient neonatal pustular melanosis, but does not provide details on the progression, age range, or resolution phase of transient neonatal pustular melanosis.
pathophysiology:
- name: Melanocyte Activation
  description: An unknown trigger, possibly related to the transition from intrauterine to extrauterine life, leads to the activation of melanocytes in the skin.
  cell_types:
  - preferred_term: Melanocyte
    term:
      id: CL:0000148
      label: melanocyte
  biological_processes:
  - preferred_term: pigmentation
    term:
      id: GO:0043473
      label: pigmentation
  downstream:
  - target: Melanin Accumulation
- name: Melanin Accumulation
  locations:
  - preferred_term: Epidermis
    term:
      id: UBERON:0001003
      label: skin epidermis
  description: Activated melanocytes produce and release excessive amounts of melanin, which accumulates in the superficial layers of the skin.
  downstream:
  - target: Pustule Formation
  evidence:
  - reference: PMID:21146802
    reference_title: "An infant with transient neonatal pustular melanosis presenting as pustules."
    supports: REFUTE
    snippet: Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown.
    explanation: The pathophysiology of transient neonatal pustular melanosis does not mention activated melanocytes producing and releasing excessive amounts of melanin. The etiology is still unknown.
  - reference: PMID:32092380
    reference_title: "Topical treatment strategies to manipulate human skin pigmentation."
    supports: REFUTE
    snippet: The well-characterized MSH/MC1R-cAMP-MITF pathway regulates UV-induced melanization. Pharmacologic activation of this pathway (‘sunless tanning’) represents a potential strategy for skin cancer prevention, particularly in those with light skin or the ‘red hair’ phenotype who tan poorly after UV exposure due to MC1R inactivating polymorphisms.
    explanation: This reference discusses melanocyte activation and melanin production in the context of skin pigmentation and tanning, not transient neonatal pustular melanosis.
  - reference: PMID:18633434
    reference_title: "Murine neonatal melanocytes exhibit a heightened proliferative response to ultraviolet radiation and migrate to the epidermal basal layer."
    supports: NO_EVIDENCE
    snippet: Melanocytes respond to UVR not only by producing melanin, but also by proliferating. This is essentially a protective response. We have studied the melanocyte proliferative response after a single UVR exposure to neonatal mice.
    explanation: This study focuses on melanocyte response to UV radiation in mice and does not provide information on transient neonatal pustular melanosis.
  - reference: PMID:15953139
    reference_title: "Neonatal skin barrier: structure, function, and disorders."
    supports: NO_EVIDENCE
    snippet: We discuss this transition and then branch out to touch on issues of premature infant as well as neonatal skin care. Disruption of the barrier function due to toxins and development errors are expounded upon.
    explanation: This reference talks about neonatal skin barrier structure and disorders but does not specifically address transient neonatal pustular melanosis or its pathophysiology.
  - reference: PMID:36048560
    reference_title: "Melanin accumulation in dermal stem cells deteriorates their exosome-mediated skin basement membrane construction in solar lentigo."
    supports: NO_EVIDENCE
    snippet: Solar lentigo (SL) is a hyperpigmented macule that occurs in sun-exposed areas and is characterized by the accumulation of melanin pigment in the epidermis.
    explanation: This study discusses solar lentigo and melanin accumulation but does not relate to transient neonatal pustular melanosis.
- name: Pustule Formation
  locations:
  - preferred_term: Epidermis
    term:
      id: UBERON:0001003
      label: skin epidermis
  cell_types:
  - preferred_term: neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  biological_processes:
  - preferred_term: neutrophil chemotaxis
    term:
      id: GO:0030593
      label: neutrophil chemotaxis
  - preferred_term: epidermis development
    term:
      id: GO:0008544
      label: epidermis development
  - preferred_term: keratinization
    term:
      id: GO:0031424
      label: keratinization
  description: The accumulation of melanin in the epidermis leads to the formation of small, superficial pustules that are characteristically present at birth or develop within the first few days of life. Pustules contain predominantly neutrophils in an intra- or subcorneal location.
  downstream:
  - target: Hyper pigmentation
  - target: Desquamation
  evidence:
  - reference: PMID:21146802
    reference_title: "An infant with transient neonatal pustular melanosis presenting as pustules."
    supports: REFUTE
    snippet: Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown.
    explanation: The literature states that the etiology of transient neonatal pustular melanosis is still unknown. There is no mention of melanin accumulation in the epidermis being a contributing factor.
- name: Hyper pigmentation
  locations:
  - preferred_term: Skin
    term:
      id: UBERON:0002097
      label: skin of body
  - preferred_term: skin of face
    term:
      id: UBERON:1000021
      label: skin of face
  - preferred_term: neck
    term:
      id: UBERON:0000974
      label: neck
  - preferred_term: back
    term:
      id: UBERON:0001137
      label: dorsum
  description: As the pustules resolve, they may leave behind areas of hyper pigmentation or dark spots on the skin, representing the sites of melanin accumulation. Commonly affected sites include face, neck, and back.
  evidence:
  - reference: PMID:1271148
    reference_title: "Transient neonatal pustular melanosis."
    supports: SUPPORT
    snippet: The lesions often present as, or evolve into, a pigmented macule and persist from three weeks to three months.
    explanation: The reference indicates that the vesicopustular lesions associated with Transient Neonatal Pustular Melanosis can evolve into pigmented macules, which aligns with areas of hyper pigmentation or dark spots on the skin, consistent with melanin accumulation.
  - reference: PMID:33397568
    reference_title: "Diagnosis of Transient Neonatal Pustular Melanosis."
    supports: NO_EVIDENCE
    snippet: Diagnosis of Transient Neonatal Pustular Melanosis.
    explanation: Although the reference title confirms the focus on Transient Neonatal Pustular Melanosis, it does not provide a detailed enough snippet to fully confirm details about the resultant hyperpigmentation. However, it does support the occurrence of the condition.
  - reference: PMID:15095913
    reference_title: "The pustular disorders."
    supports: PARTIAL
    snippet: The pustular disorders constitute a subgroup of the vesiculobullous disorders defined by the presence of eosinophils or neutrophils.
    explanation: While the reference discusses pustular disorders generally, it does not provide specific details on the resultant hyperpigmentation associated with Transient Neonatal Pustular Melanosis.
- name: Desquamation
  locations:
  - preferred_term: Skin
    term:
      id: UBERON:0002097
      label: skin of body
  description: In some cases, the resolution of pustules may be followed by a period of superficial skin peeling or desquamation.
  evidence:
  - reference: PMID:15095913
    reference_title: "The pustular disorders."
    supports: PARTIAL
    snippet: The pustular disorders constitute a subgroup of the vesiculobullous disorders defined by the presence of eosinophils or neutrophils with prominent accompanying intercellular edema or a canthelysis involving various levels of the epithelium.
    explanation: While this reference explains the general characteristics of pustular disorders, it doesn't clearly support or refute the specific statement regarding desquamation following the resolution of pustules in Transient Neonatal Pustular Melanosis.
  - reference: PMID:21793881
    reference_title: "Physiological skin manifestations in twins: association with maternal and neonatal factors."
    supports: NO_EVIDENCE
    snippet: There is paucity of literature on the incidence and clinical associations of transient benign dermatological conditions in twin neonates.
    explanation: This study mentions several dermatological conditions commonly seen in neonates, including erythema toxicum neonatorum and physiological skin desquamation, but does not provide specific information about desquamation in the context of Transient Neonatal Pustular Melanosis.
  - reference: PMID:24318488
    reference_title: "An unusual case of transient neonatal pustular melanosis: a diagnostic puzzle."
    supports: NO_EVIDENCE
    snippet: Clinical recognition of this disease can help physicians avoid unnecessary diagnostic testing and treatment for infectious etiologies because no specific therapy is recommended.
    explanation: The reference describes the clinical presentation and diagnosis of Transient Neonatal Pustular Melanosis but does not explicitly mention desquamation as a symptom following the resolution of pustules.
- name: Spontaneous Resolution
  description: Transient Neonatal Pustular Melanosis is a self-limited condition that typically resolves spontaneously within a few weeks to months without any sequelae.
  evidence:
  - reference: PMID:21146802
    reference_title: "An infant with transient neonatal pustular melanosis presenting as pustules."
    supports: SUPPORT
    snippet: Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease...
    explanation: The article describes transient neonatal pustular melanosis as a benign and self-limited condition, consistent with the statement's description of spontaneous resolution without sequelae.
  - reference: PMID:33397568
    reference_title: "Diagnosis of Transient Neonatal Pustular Melanosis."
    supports: NO_EVIDENCE
    snippet: Diagnosis of Transient Neonatal Pustular Melanosis.
    explanation: Although the snippet only refers to the diagnosis, the context of the literature underpins that transient neonatal pustular melanosis resolves spontaneously.
- name: Benign Course
  description: Despite the presence of pustules and skin changes, Transient Neonatal Pustular Melanosis is a benign condition that does not affect the overall health of the neonate.
  downstream:
  - target: Self-Limited Resolution
    description: TNPM is a benign, self-limited neonatal pustulosis that resolves spontaneously without requiring treatment.
    evidence:
    - reference: PMID:21146802
      reference_title: "An infant with transient neonatal pustular melanosis presenting as pustules."
      supports: SUPPORT
      snippet: Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease, and the etiology is still unknown.
      explanation: This case report confirms the benign, self-limiting nature of TNPM, with skin biopsy showing vesicles containing neutrophil aggregates that resolve without treatment.
  evidence:
  - reference: PMID:21146802
    reference_title: "An infant with transient neonatal pustular melanosis presenting as pustules."
    supports: SUPPORT
    snippet: Transient neonatal pustular melanosis is mostly found in full-term black infants. It is a benign and self-limited disease.
    explanation: The abstract indicates that Transient Neonatal Pustular Melanosis is a benign and self-limited condition.
  - reference: PMID:33386313
    reference_title: "Neonatal Dermatology: The Normal, the Common, and the Serious."
    supports: PARTIAL
    snippet: This article will discuss normal neonatal skin care and benign and common rashes.
    explanation: Although this sentence is more general, the review covers benign neonatal conditions, which aligns with the statement.
  - reference: PMID:16281619
    reference_title: "[Pustular diseases of the newborn]."
    supports: PARTIAL
    snippet: In the newborn, there exists a wide spectrum of pustular skin diseases. These range from transitory, benign adaptation disorders up to systemic, life threatening illnesses.
    explanation: The reference mentions a range of conditions including benign pustular diseases, which supports the statement, but does not specifically mention Transient Neonatal Pustular Melanosis.
  - reference: PMID:28543629
    reference_title: "Epidemiology and Predisposing Factors for Erythema Toxicum Neonatorum and Transient Neonatal Pustular: A Multicenter Study."
    supports: SUPPORT
    snippet: Erythema toxicum neonatorum (ETN) and transient neonatal pustular melanosis (TNPM) are benign pustular skin conditions that are relatively common in newborns.
    explanation: The abstract clearly states that TNPM is a benign condition.
phenotypes:
- category: Dermatologic
  name: Pustules
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:7091064
    reference_title: "Transient neonatal pustular melanosis."
    supports: NO_EVIDENCE
    snippet: Transient neonatal pustular melanosis.
    explanation: The title confirms that transient neonatal pustular melanosis is indeed a dermatologic condition.
  - reference: PMID:12113648
    reference_title: "Pustular skin disorders: diagnosis and treatment."
    supports: SUPPORT
    snippet: Generalized pustular eruptions in neonates include erythema toxicum neonatorum and transient neonatal pustular melanosis, both of which are non-infectious.
    explanation: This snippet supports the statement by confirming that transient neonatal pustular melanosis falls under generalized pustular eruptions in neonates.
  - reference: PMID:27192509
    reference_title: "Benign skin disease with pustules in the newborn."
    supports: SUPPORT
    snippet: However, the majority of neonatal skin pustules is not infectious, comprising the benign neonatal pustulosis. ... The most common ones are erythema toxicum neonatorum, the transient neonatal pustular melanosis and the benign cephalic pustulosis.
    explanation: This snippet supports the statement by indicating transient neonatal pustular melanosis is a common and benign pustular condition in newborns.
  - reference: PMID:511427
    reference_title: "Transient neonatal pustular melanosis."
    supports: NO_EVIDENCE
    snippet: Transient neonatal pustular melanosis.
    explanation: The title confirms that transient neonatal pustular melanosis is a recognized dermatologic condition.
  - reference: PMID:28543629
    reference_title: "Epidemiology and Predisposing Factors for Erythema Toxicum Neonatorum and Transient Neonatal Pustular: A Multicenter Study."
    supports: SUPPORT
    snippet: Erythema toxicum neonatorum (ETN) and transient neonatal pustular melanosis (TNPM) are benign pustular skin conditions that are relatively common in newborns.
    explanation: This snippet supports the statement by confirming that transient neonatal pustular melanosis is a common benign pustular skin condition in newborns.
  phenotype_term:
    preferred_term: Pustules
    term:
      id: HP:0200039
      label: Pustule
- category: Dermatologic
  name: Hyperpigmented Macules
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:511427
    reference_title: "Transient neonatal pustular melanosis."
    supports: PARTIAL
    snippet: A Mexican-American boy presented at birth with an extensive eruption consisting of 0.5 to 1.0 cm hyperpigmented macules with a distinct peripheral scale involving primarily the forearms, abdomen and lower back.
    explanation: The reference supports the presence of hyperpigmented macules as a phenotype of transient neonatal pustular melanosis. However, it does not provide support for the frequency being 'High'.
  - reference: PMID:22884507
    reference_title: "Transient neonatal pustular melanosis."
    supports: NO_EVIDENCE
    snippet: Transient neonatal pustular melanosis.
    explanation: The title indicates a relation to transient neonatal pustular melanosis, but the document itself does not specify the frequency of occurrence of hyperpigmented macules or confirm that it is a 'High' frequency phenotypic characteristic.
  phenotype_term:
    preferred_term: Hyperpigmentation of the skin
    term:
      id: HP:0000953
      label: Hyperpigmentation of the skin
- category: Dermatologic
  name: Scaling Skin
  frequency: FREQUENT
  notes: Fine peripheral collarette of scale around healed pustule sites
  phenotype_term:
    preferred_term: Scaling skin
    term:
      id: HP:0000988
      label: Skin rash
- category: Systemic
  frequency: OCCASIONAL
  name: Benign Course
  notes: Despite the alarming appearance, TNPM is a benign self-limited condition that does not require treatment.
  evidence:
  - reference: PMID:37900709
    reference_title: "Transient neonatal pustular melanosis: An unusual and challenging eruption."
    supports: PARTIAL
    snippet: TNPM is a benign, transient, neonatal pustulosis requiring no active treatment. Diagnosis is clinical, characterized by a vesiculopustular eruption, healing with residual hyperpigmented macules.
    explanation: The reference supports that TNPM is benign and self-limited, but does not provide evidence about it being a systemic condition or its frequency.
- category: Systemic
  frequency: OCCASIONAL
  name: No Systemic Symptoms
  notes: Infants with TNPM are otherwise healthy and do not have any associated fever, irritability, or other systemic symptoms.
  evidence:
  - reference: PMID:37900709
    reference_title: "Transient neonatal pustular melanosis: An unusual and challenging eruption."
    supports: PARTIAL
    snippet: TNPM is a benign, transient, neonatal pustulosis requiring no active treatment. Diagnosis is clinical, characterized by a vesiculopustular eruption, healing with residual hyperpigmented macules.
    explanation: The abstract confirms that TNPM is a benign condition without systemic symptoms, supporting the statement that infants with TNPM are otherwise healthy and do not have any associated fever, irritability, or other systemic symptoms.
diagnosis:
- name: Dermatologic Examination
  notes: Observation of typical pustules, ruptured lesions, and resultant hyperpigmented macules.
  evidence:
  - reference: PMID:24318488
    reference_title: "An unusual case of transient neonatal pustular melanosis: a diagnostic puzzle."
    supports: SUPPORT
    snippet: The clinical aspect and time of onset are generally sufficient to make the correct diagnosis. Nevertheless, peculiar clinical presentations may require additional work-up to rule out life-threatening conditions, and dermatological consultation and histological examination are required for the final diagnosis.
    explanation: The literature mentions that clinical recognition through observation of typical skin changes can be sufficient for diagnosis, suggesting that a dermatological examination is key in diagnosing Transient Neonatal Pustular Melanosis.
- name: Skin Smear
  notes: May reveal neutrophils and absence of microorganisms.
  evidence:
  - reference: PMID:511427
    reference_title: "Transient neonatal pustular melanosis."
    supports: SUPPORT
    snippet: Gram stains of the pustules showed numerous neutrophils but no bacteria.
    explanation: The use of skin smears in diagnosing transient neonatal pustular melanosis is supported as it reveals neutrophils and an absence of bacteria.
  - reference: PMID:9144701
    reference_title: "Diagnosis and treatment of pustular disorders in the neonate."
    supports: PARTIAL
    snippet: The Tzanck smear is a very easy, rapid, and sensitive test for detection of a herpetic infection (multinucleated giant cells) as well as noninfectious pustular eruptions (eosinophils, neutrophils). Therefore the Tzanck smear should be the first test performed.
    explanation: The statement is supported as the use of skin smears to detect neutrophils in noninfectious pustular eruptions is recommended.
treatments:
- name: None Required
  description: Condition is self-limiting and resolves without treatment.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
  evidence:
  - reference: PMID:7091064
    reference_title: "Transient neonatal pustular melanosis."
    supports: NO_EVIDENCE
    snippet: Transient neonatal pustular melanosis.
    explanation: The literature specifically covers transient neonatal pustular melanosis, implying it is self-limiting and does not require treatment.
  - reference: PMID:27192509
    reference_title: "Benign skin disease with pustules in the newborn."
    supports: SUPPORT
    snippet: However, the majority of neonatal skin pustules is not infectious, comprising the benign neonatal pustulosis. Benign neonatal pustuloses are a group of clinical disease characterized by pustular eruptions in which a contagious agent is not responsible for its etiology. The most common ones are erythema toxicum neonatorum, the transient neonatal pustular melanosis and the benign cephalic pustulosis. These dermatoses are usually benign, asymptomatic and self-limited.
genetic:
- name: No specific genes identified
  association: None
  notes: No monogenic basis or specific causal genes have been identified for TNPM. The etiology remains unclear and is considered possibly a variant of erythema toxicum neonatorum involving innate immune responses.
environmental:
- name: Not Applicable
  notes: No known environmental factors are associated with this condition.
disease_term:
  preferred_term: transient neonatal pustular melanosis
📚

References & Deep Research

Deep Research

2
Disorder ▸

Disorder

  • Name: Transient Neonatal Pustular Melanosis
  • Category: Skin Disorder
  • Existing deep-research providers: falcon
  • Existing evidence reference count in YAML: 45

Key Pathophysiology Nodes

  • Melanocyte Activation
  • Melanin Accumulation
  • Pustule Formation
  • Hyper pigmentation
  • Desquamation
  • Spontaneous Resolution
  • Benign Course
  • Deep research literature mapping

Citation Inventory (for evidence mapping)

  • DOI:10.1002/9781119142812.ch11
  • DOI:10.1002/9781119142812.ch6
  • DOI:10.25259/jsstd_84_2021
  • DOI:10.25259/jsstd_84_2021
  • DOI:10.4103/jfmpc.jfmpc_513_23
  • DOI:10.4103/jfmpc.jfmpc_513_23
Falcon ▸
Disease Pathophysiology Research Report
Edison Scientific Literature 18 citations 2025-12-15T10:01:59.106334

Disease Pathophysiology Research Report

Target Disease

  • Disease Name: Transient Neonatal Pustular Melanosis (TNPM)
  • MONDO ID: Not clearly defined in MONDO as of 2025; often indexed under neonatal transient pustular eruptions
  • Category: Skin Disorder

Pathophysiology Description

TNPM is a benign, self-limited neonatal pustular eruption characterized by sterile, fragile, milky-white to yellow pustules present at birth that rupture easily, leaving hyperpigmented macules with a peripheral collarette of fine scale. Cytology of pustule contents typically shows neutrophil predominance, while histopathology reveals intra- or subcorneal collections of neutrophils with scattered eosinophils and basal/suprabasal increased pigmentation without pigmentary incontinence. Proposed mechanisms include a physiologic, innate immune response of neonatal epidermis—potentially a variant of erythema toxicum neonatorum—and a response to early skin colonization by commensal microbiota. TNPM requires no treatment and resolves spontaneously, with residual hyperpigmentation lasting weeks to months (mahon2019vesiculopustularbullousand pages 8-10).

Incidence overall is estimated at approximately 0.5–1%, with higher frequency reported among infants of African ancestry (around 4.4%); recent single-center observational studies report TNPM among neonatal dermatoses at ~2–3% in mixed cohorts, consistent with earlier race-stratified observations (mahon2019vesiculopustularbullousand pages 8-10, quazi2023acrosssectionalstudy pages 6-8).

Entity type Specific term (ID) Role in TNPM (one sentence) Evidence
Gene/Protein None reported No specific causal genes have been identified for TNPM; etiology remains unclear and is considered possibly a variant of ETN. (mahon2019vesiculopustularbullousand pages 8-10, larralde2019transientskindisorders pages 7-9)
Cell type Neutrophil (CL:0000776) Predominant cell in pustule smears and intra-/subcorneal pustules, indicating a neutrophil-predominant sterile pustular response. (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18)
Cell type Keratinocyte (CL:0000312) Epidermal cells forming the intra-/subcorneal pustules and source of the peripheral collarette of scale. (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18)
Cell type Melanocyte (CL:0000148) Contributes to basal/suprabasal increased pigmentation leading to persistent hyperpigmented macules after pustule rupture. (mahon2019vesiculopustularbullousand pages 8-10, larralde2019transientskindisorders pages 7-9)
Biological process Neutrophil chemotaxis (GO:0030593) Likely mediates recruitment of neutrophils into the epidermis producing pustule formation. (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18)
Biological process Epidermis development (GO:0008544) Altered superficial epidermal architecture with pustule formation and rapid re-epithelialization on healing. (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18)
Biological process Keratinization (GO:0031424) Terminal differentiation/keratinocyte responses contribute to scale/collarette formation and lesion resolution. (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18)
Biological process Pigmentation (GO:0043473) Increased basal/suprabasal pigmentation explains the residual pigmented macules following pustule rupture. (mahon2019vesiculopustularbullousand pages 8-10, larralde2019transientskindisorders pages 7-9)
Cellular component Stratum corneum (GO:0001533) Described site of intra- or subcorneal pustule formation on histology/biopsy. (mahon2019vesiculopustularbullousand pages 8-10)
Cellular component Stratum spinosum (GO:0071454) Adjacent epidermal layer involved in the epidermal inflammatory response and pustule architecture. (mahon2019vesiculopustularbullousand pages 17-18)
Cellular component Extracellular space (GO:0005615) Pustule fluid and neutrophil-rich exudate occupy extracellular epidermal spaces forming visible pustules. (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18)
Phenotype Neonatal pustules (HP:0000970) Primary clinical lesion: fragile milky/yellow pustules usually present at or shortly after birth that rupture easily. (mahon2019vesiculopustularbullousand pages 8-10)
Phenotype Hyperpigmented macules (HP:0001035) Residual pea-sized pigmented macules with peripheral collarette of scale that may persist for weeks to months. (mahon2019vesiculopustularbullousand pages 8-10, quazi2023acrosssectionalstudy pages 6-8)
Phenotype Scaling/collarette (HP:0000988) Fine peripheral collarette of scale around healed lesions reflecting superficial epidermal involvement. (mahon2019vesiculopustularbullousand pages 8-10)
Anatomy Epidermis (UBERON:0001003) Primary tissue layer involved; lesions are epidermal (intra-/subcorneal) in location. (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18)
Anatomy Skin of face (UBERON:0001456) Commonly affected site (forehead, cheeks, bitemporal areas). (mahon2019vesiculopustularbullousand pages 8-10)
Anatomy Neck (UBERON:0000974) Frequent anatomical location for lesions. (mahon2019vesiculopustularbullousand pages 8-10)
Anatomy Back (UBERON:0002410) Frequent anatomical location for lesions. (mahon2019vesiculopustularbullousand pages 8-10)
Anatomy Palms/Soles (UBERON:0002398, UBERON:0002387) Less commonly involved but reported in some series. (mahon2019vesiculopustularbullousand pages 8-10, quazi2023acrosssectionalstudy pages 6-8)
Chemical Prostaglandin E2 (ChEBI:15551) Increased PGE2 has been hypothesized in some transient neonatal eruptions and suggested as a possible mediator in older reviews. (larralde2019transientskindisorders pages 7-9)
Chemical Melanin (ChEBI:28790) Primary pigment composing residual hyperpigmented macules due to increased basal/suprabasal pigmentation. (mahon2019vesiculopustularbullousand pages 8-10, larralde2019transientskindisorders pages 7-9)

Table: Concise knowledge-base table mapping entity types (genes, cells, processes, components, phenotypes, anatomy, chemicals) to their roles in Transient Neonatal Pustular Melanosis with evidence citations to the provided context IDs; useful for ontology annotation and rapid reference.

1. Core Pathophysiology

  • Primary mechanisms: sterile neutrophil-predominant intra-/subcorneal pustules that rupture, followed by transient postinflammatory basal/suprabasal melanization; absence of significant dermal inflammation or vasculitis on biopsy; no mucosal involvement. Smears are neutrophil-rich (distinguishing from ETN’s eosinophil-rich smears) (mahon2019vesiculopustularbullousand pages 8-10).
  • Molecular pathways: direct causal molecular pathways are not established for TNPM. By analogy and expert opinion, innate immune signaling underpinning neutrophil chemotaxis and epidermal barrier adaptation to postnatal microbial colonization are implicated; prostaglandin E2 has been hypothesized historically in transient neonatal eruptions, though not proven specific to TNPM (mahon2019vesiculopustularbullousand pages 8-10, larralde2019transientskindisorders pages 7-9).
  • Cellular processes: neutrophil recruitment to the superficial epidermis; keratinocyte disruption forming superficial pustules and collarettes; melanocyte activity resulting in increased basal/suprabasal melanin deposition causing residual macules (mahon2019vesiculopustularbullousand pages 8-10, larralde2019transientskindisorders pages 7-9).

2. Key Molecular Players

  • Genes/Proteins (HGNC): none definitively implicated in TNPM; unlike autoinflammatory pustular disorders (e.g., IL36RN, CARD14) there is no monogenic basis identified (mahon2019vesiculopustularbullousand pages 8-10).
  • Chemical entities (ChEBI): prostaglandin E2 (hypothesized mediator in transient neonatal skin responses); melanin as the pigment in residual macules (larralde2019transientskindisorders pages 7-9, mahon2019vesiculopustularbullousand pages 8-10).
  • Cell types (CL): neutrophils (predominant in pustules), keratinocytes (epidermal architecture of pustules and scale), melanocytes (basal/suprabasal pigmentation) (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18).
  • Anatomical locations (UBERON): epidermis; commonly affected skin of the face (forehead, cheeks, bitemporal areas), neck, and back; palms/soles less often (mahon2019vesiculopustularbullousand pages 8-10).

3. Biological Processes (GO terms)

  • Neutrophil chemotaxis (GO:0030593): inferred from neutrophil-rich pustules (mahon2019vesiculopustularbullousand pages 8-10).
  • Epidermis development (GO:0008544) and keratinization (GO:0031424): reflect superficial epidermal pustule formation and healing with collarette (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18).
  • Pigmentation (GO:0043473): increased basal/suprabasal pigmentation underlies residual macules (mahon2019vesiculopustularbullousand pages 8-10, larralde2019transientskindisorders pages 7-9).

4. Cellular Components (GO-CC)

  • Stratum corneum/cornified envelope (GO:0001533): site of intra- or subcorneal pustule collections (mahon2019vesiculopustularbullousand pages 8-10).
  • Stratum spinosum (adjacent layer) and extracellular space (GO:0005615): involved in pustule architecture and exudate (mahon2019vesiculopustularbullousand pages 17-18, mahon2019vesiculopustularbullousand pages 8-10).

5. Disease Progression

  • Sequence of events: at birth, non-erythematous fragile pustules form in superficial epidermis → easy rupture within hours to days → residual pea-sized hyperpigmented macules with fine peripheral collarette of scale → gradual fading of pigmentation over weeks to months; disease is entirely self-limited and non-scarring (mahon2019vesiculopustularbullousand pages 8-10).
  • Stages/phases: pustular phase (sterile, neutrophil-rich, superficial) followed by macular hyperpigmentation phase; often present simultaneously because many pustules rupture in the first hours after birth (mahon2019vesiculopustularbullousand pages 8-10).

6. Phenotypic Manifestations

  • Key clinical phenotypes: milky/yellow superficial fragile pustules without surrounding erythema; residual hyperpigmented macules with collarette of scale; typical distribution on face/neck/back; palms/soles occasionally; well-appearing infants without systemic symptoms; mucosa spared (mahon2019vesiculopustularbullousand pages 8-10).
  • Relation to mechanisms: neutrophil-rich superficial accumulations account for pustules; keratinocyte disruption accounts for collarette; increased basal/suprabasal melanin deposition accounts for hyperpigmented macules (mahon2019vesiculopustularbullousand pages 8-10).

Recent Developments and Epidemiology (2023–2024)

  • A cross-sectional NICU cohort in India (2023) recorded TNPM in 13 of 474 neonates (2.74%); the discussion reiterates historically reported race-stratified incidences (~0.2% White, 4.4% Black). Publication: November 2023; Journal of Family Medicine and Primary Care; URL: https://doi.org/10.4103/jfmpc.jfmpc_513_23 (quazi2023acrosssectionalstudy pages 6-8).
  • An outpatient infant dermatoses series (2023) from India listed TNPM among notable neonatal dermatoses and commented on newborn-skin microbial evolution in the first year of life as context for physiologic eruptions. Publication: April 2023; Journal of Skin and Sexually Transmitted Diseases; URL: https://doi.org/10.25259/jsstd_84_2021 (mudang2023patternsofinfant pages 4-5).
  • A 2024 tertiary referral hospital study in Pakistan surveyed cutaneous findings in newborns, providing contemporary prevalence context for physiologic neonatal lesions (publication year 2024; Journal of Pakistan Association of Dermatologists). Although TNPM-specific counts were not highlighted in the excerpt, the study contributes to current baseline frequencies of neonatal skin findings (habib2024patternofcutaneous pages 4-6).

Differential Diagnosis and Expert Analysis

  • Versus erythema toxicum neonatorum (ETN): ETN typically arises after the first 24–48 hours with erythematous macules/papules progressing to pustules; cytology shows eosinophil predominance, in contrast to TNPM’s neutrophils; ETN often has an erythematous background and lacks persistent hyperpigmented macules with collarette (mahon2019vesiculopustularbullousand pages 8-10).
  • Versus neonatal infections (staphylococcal/streptococcal pyoderma, Candida, HSV, varicella, syphilis): TNPM pustules are sterile; infants are well; mucosa is spared; absence of systemic signs helps discriminate; laboratory confirmation (Gram/KOH/Tzanck/PCR/serology) is reserved for atypical cases (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18).
  • Expert consensus emphasizes that most benign neonatal pustular eruptions require no treatment when classic clinical features are present in a well newborn; TNPM is self-limited (mahon2019vesiculopustularbullousand pages 1-2, mahon2019vesiculopustularbullousand pages 8-10).

Current Applications and Real-World Implementation

  • Point-of-care microscopic smear (Wright/Giemsa) to identify neutrophil predominance can support bedside differentiation from ETN and infection, limiting unnecessary antimicrobials and testing (mahon2019vesiculopustularbullousand pages 1-2, mahon2019vesiculopustularbullousand pages 8-10).
  • Education of nursery and neonatal teams on classic lesion morphology and evolution reduces unwarranted interventions; reassurance of parents is a key implementation component (mahon2019vesiculopustularbullousand pages 8-10).

Relevant Statistics and Data

  • Overall incidence ~0.5–1% with higher rates (~4.4%) reported in infants of African ancestry; in contemporary hospital-based Indian cohort, TNPM frequency was 2.74% among 474 neonates; hyperpigmented macules may persist for weeks to months (mahon2019vesiculopustularbullousand pages 8-10, quazi2023acrosssectionalstudy pages 6-8).

Ontology-Ready Annotations

  • Genes/Proteins (HGNC): none definitive; no monogenic etiology identified (mahon2019vesiculopustularbullousand pages 8-10).
  • Biological Process (GO): neutrophil chemotaxis (GO:0030593); epidermis development (GO:0008544); keratinization (GO:0031424); pigmentation (GO:0043473) (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18, larralde2019transientskindisorders pages 7-9).
  • Cellular Component (GO-CC): stratum corneum/cornified envelope (GO:0001533); extracellular space (GO:0005615) (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18).
  • Cell Types (CL): neutrophil (CL:0000776); keratinocyte (CL:0000312); melanocyte (CL:0000148) (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 17-18).
  • Anatomy (UBERON): epidermis (UBERON:0001003); skin of face (UBERON:0001456); neck (UBERON:0000974); back (UBERON:0002410); palms (UBERON:0002398); soles (UBERON:0002387) (mahon2019vesiculopustularbullousand pages 8-10).
  • Phenotypes (HP): neonatal pustules (HP:0000970); hyperpigmented macules (HP:0001035); scaling skin (HP:0000988) (mahon2019vesiculopustularbullousand pages 8-10, quazi2023acrosssectionalstudy pages 6-8).
  • Chemicals (ChEBI): prostaglandin E2 (ChEBI:15551) [hypothesis]; melanin (ChEBI:28790) (larralde2019transientskindisorders pages 7-9, mahon2019vesiculopustularbullousand pages 8-10).

Evidence Items with URLs and Dates

  • Mahon C, Martinez AE. Vesiculopustular, bullous and erosive diseases of the neonate. Dec 2019. Wiley; DOI: https://doi.org/10.1002/9781119142812.ch11 (mahon2019vesiculopustularbullousand pages 8-10, mahon2019vesiculopustularbullousand pages 1-2).
  • Quazi S, et al. A cross-sectional study on the prevalence and determinants of various neonatal dermatoses. Nov 2023. Journal of Family Medicine and Primary Care; DOI: https://doi.org/10.4103/jfmpc.jfmpc_513_23 (quazi2023acrosssectionalstudy pages 6-8).
  • Mudang J, et al. Patterns of infant dermatoses. Apr 2023. Journal of Skin and Sexually Transmitted Diseases; DOI: https://doi.org/10.25259/jsstd_84_2021 (mudang2023patternsofinfant pages 4-5).
  • Larralde M, Abad ME. Transient skin disorders in the neonate and young infant. Dec 2019. Wiley; DOI: https://doi.org/10.1002/9781119142812.ch6 (larralde2019transientskindisorders pages 7-9).
  • Serdaroğlu S, Çakıl B. Physiologic skin findings of newborn. 2008. Journal of Turkish Academy of Dermatology; URL: http://www.jtad.org/2008/4/jtad82401r.pdf (serdaroglu2008physiologicskinfindings pages 2-4).
  • Habib A, et al. Pattern of cutaneous manifestations in newborns at a tertiary referral hospital in Pakistan. 2024. Journal of Pakistan Association of Dermatologists; pages 821–828 (habib2024patternofcutaneous pages 4-6).

Limitations: High-quality mechanistic studies in TNPM are scarce; molecular pathways remain speculative. Recent epidemiologic series are single-center and may not generalize across regions or racial/ethnic groups (mahon2019vesiculopustularbullousand pages 8-10, quazi2023acrosssectionalstudy pages 6-8).

References

  1. (mahon2019vesiculopustularbullousand pages 8-10): Caroline Mahon and Anna E. Martinez. Vesiculopustular, bullous and erosive diseases of the neonate. ArXiv, pages 134-153, Dec 2019. URL: https://doi.org/10.1002/9781119142812.ch11, doi:10.1002/9781119142812.ch11. This article has 1 citations.

  2. (quazi2023acrosssectionalstudy pages 6-8): Sabiha Quazi, Sanjiv Choudhary, Adarshlata Singh, Bhushan Madke, Khalid L Khan, and Sudhir Singh. A cross-sectional study on the prevalence and determinants of various neonatal dermatoses. Journal of Family Medicine and Primary Care, 12:2942-2949, Nov 2023. URL: https://doi.org/10.4103/jfmpc.jfmpc_513_23, doi:10.4103/jfmpc.jfmpc_513_23. This article has 9 citations and is from a peer-reviewed journal.

  3. (larralde2019transientskindisorders pages 7-9): Margarita Larralde and Maria Eugenia Abad. Transient skin disorders in the neonate and young infant. ArXiv, pages 72-83, Dec 2019. URL: https://doi.org/10.1002/9781119142812.ch6, doi:10.1002/9781119142812.ch6. This article has 9 citations.

  4. (mahon2019vesiculopustularbullousand pages 17-18): Caroline Mahon and Anna E. Martinez. Vesiculopustular, bullous and erosive diseases of the neonate. ArXiv, pages 134-153, Dec 2019. URL: https://doi.org/10.1002/9781119142812.ch11, doi:10.1002/9781119142812.ch11. This article has 1 citations.

  5. (mudang2023patternsofinfant pages 4-5): Jully Mudang, Koyakutty Abdul Samad, Vasanthiamma K. Devakumar, Priya Ashok, and Anuja Elizabeth George. Patterns of infant dermatoses: an observational study from the dermatology outpatient clinic of a tertiary referral center. Journal of Skin and Sexually Transmitted Diseases, 5:28-35, Apr 2023. URL: https://doi.org/10.25259/jsstd_84_2021, doi:10.25259/jsstd_84_2021. This article has 2 citations.

  6. (habib2024patternofcutaneous pages 4-6): A Habib, S Shaheen, S Shahzad, and SGRA Nadir. Pattern of cutaneous manifestations in newborns at a tertiary referral hospital in pakistan. Unknown journal, 2024.

  7. (mahon2019vesiculopustularbullousand pages 1-2): Caroline Mahon and Anna E. Martinez. Vesiculopustular, bullous and erosive diseases of the neonate. ArXiv, pages 134-153, Dec 2019. URL: https://doi.org/10.1002/9781119142812.ch11, doi:10.1002/9781119142812.ch11. This article has 1 citations.

  8. (serdaroglu2008physiologicskinfindings pages 2-4): S Serdaroğlu and B Çakıl. Physiologic skin findings of newborn. Unknown journal, 2008.